Linezolid is a synthetic antibiotic in the oxazolidinone class, effective against a broad range of Gram-positive bacteria, including multidrug-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE). It works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth. Linezolid is used to treat various infections, including nosocomial pneumonia, community-acquired pneumonia, complicated skin and soft tissue infections, and infections caused by resistant bacteria. It is available in oral and intravenous formulations, offering flexibility in treatment